Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/17/2001 | EP1015430A4 Spiro pyrrolidine-2,3'-oxindole] compounds and methods of use |
01/17/2001 | EP1003501A4 Means of ascertaining an individual's risk profile for atherosclerotic disease |
01/17/2001 | EP0970365A4 Apparatus and methods for capture and analysis of particulate entities |
01/17/2001 | EP0882226A4 Electrochemical method |
01/17/2001 | EP0788555B1 Methods of analysis and manipulation of dna utilizing mismatch repair systems |
01/17/2001 | EP0589982B1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
01/17/2001 | EP0539495B1 Device and method for measuring hdl-cholesterol employing precipitation on a solid-phase |
01/17/2001 | CN2415376Y Apparatus for testing time of activating whole blood coagulation |
01/17/2001 | CN2415356Y Tube type micro liquid distributor for making biological water |
01/17/2001 | CN1280673A Improved electrochemical biosensor test strip |
01/17/2001 | CN1280670A A Sampling device for thermal analysis |
01/17/2001 | CN1280627A Proteinase inhibitor fusion proteins |
01/17/2001 | CN1280623A Method and compositions useful for activation of silent transgenes |
01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
01/17/2001 | CN1280618A Protein involved in abscisic acid signalling |
01/17/2001 | CN1280611A Method and compositions for binding hematopoietic stem cells |
01/17/2001 | CN1280483A Site-specitic preparation of polyethylene glycol-GRF conjujates |
01/17/2001 | CN1280299A Central identifying for nucleic acid samples and method for result feedback |
01/17/2001 | CN1060861C Flow colorimeter cup for biochemical enalyzer |
01/16/2001 | US6175409 Flow-injection analysis and variable-flow light-scattering methods and apparatus for characterizing polymers |
01/16/2001 | US6175408 Apparatus for detecting foreign substance in strand-like textile material |
01/16/2001 | US6175111 Method for diagnosis of components inside turbine generator |
01/16/2001 | US6175016 Such as 3-hydroxy-1-(5-amino-5-carboxy-pentyl)-4-(1-amino-1-carboxy-2-ethyl)-5-(3 -amino-3-carboxy-propyl) pyridinium hydrochloride; making via cyclization reaction; for use in diagnosing bone and connective tissue disorders |
01/16/2001 | US6174994 7TM receptor (H2CAA71) |
01/16/2001 | US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes |
01/16/2001 | US6174740 Applying mechanical damage onto surface of silicon wafer to form distortions; oxidizing to form thermal oxide film on wafer surface; dissolving thermal oxide film with chemical solution or vapor; determining bulk impurities |
01/16/2001 | US6174734 Measurement of glycated hemoglobin |
01/16/2001 | US6174733 Detection of pathogens using a column device with a sample containing a control |
01/16/2001 | US6174732 Analytical methodology for qualitative and quantitative determination of chemical agent vapor |
01/16/2001 | US6174731 Reagent for the PH-metric determination of low acid numbers in petroleum oils |
01/16/2001 | US6174729 Accurate, simple method by applying protein solution to porous support, solution diffuses in presence of detergent and salt and/or acid to form uniform spot, measuring size of spot, comparing to standard |
01/16/2001 | US6174728 Scattering calibration particles dispersed in aqueous electrolyte solution; particles have mean diameter of less than 0.06 micrometers and volume concentration of less than 0.3 %; nonsettling; storage stability |
01/16/2001 | US6174727 Method of detecting microscopic defects existing on a silicon wafer |
01/16/2001 | US6174723 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
01/16/2001 | US6174714 Lyss |
01/16/2001 | US6174700 Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation |
01/16/2001 | US6174698 Applying precise, focused energy to photoactivate; testing fragility |
01/16/2001 | US6174696 Method for the determination of homocysteine |
01/16/2001 | US6174694 Phosphorylation of serine containing substrate; incubate substrate with adenosine triphosphate and a enzymatic protein, monitor the amount of phosphorylation |
01/16/2001 | US6174693 Immunological assay for protein activity |
01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
01/16/2001 | US6174690 Detecting sodium channel modulators; incubate cells expressing sodium channels with indicator and monitor suspension for color, change in color is indicative of activation by modulators |
01/16/2001 | US6174688 Immunoassay; mix antibody and control sample, mix second control sample, modulator and antibody, incubate sample and antibody, incubate sample, modulator and antibody, compare control and sample values, count antigen and modulator |
01/16/2001 | US6174687 Methods of identifying lung homing molecules using membrane dipeptidase |
01/16/2001 | US6174686 Detecting muscle protein isoforms in blood sample; incubate blood sample with suppressor which dissociates complexed mucsle protein isoforms, incubate sample with antibody specific for muscle protein, detect signal from antibody |
01/16/2001 | US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
01/16/2001 | US6174683 Immobilization of biomolecular probes by using derivatized polyurethane-based hydrogels; stability, genetic engineering |
01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
01/16/2001 | US6174670 Achieved with rapid thermal cycling and use of double stranded dna dyes or specific hybridization probes |
01/16/2001 | US6174667 Bovine viral diarrhea virus serum antigen capture |
01/16/2001 | US6174665 Monitoring treatment of menopause; obtaining a body fluid sample and counting amount of progesterone, testosterone, estradiol, follicle stimulating hormone, and estriol, administering and adjusting compounds as needed |
01/16/2001 | US6174664 Screening method for inflammatory diseases using neutrophil defensins and lactoferrin |
01/16/2001 | US6174497 Detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form |
01/16/2001 | US6174066 Light device for verifying the possible presence of solid deposits and other impurities inside a bottle of wine |
01/16/2001 | CA2313860A1 Initiation of an analytical measurement |
01/16/2001 | CA2206602C Sequential delivery of purified biological and chemical reagents |
01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
01/16/2001 | CA2164707C Technetium-99m labeled peptides for imaging inflammation |
01/16/2001 | CA2138536C Chemiluminescent assay for dsdna antibodies |
01/16/2001 | CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus |
01/16/2001 | CA2029488C Prevacuum steam sterilization test pack |
01/16/2001 | CA2010800C Protein labelling |
01/16/2001 | CA1341170C Calcium channel compositions and methods |
01/15/2001 | CA2277596A1 Improved surface ionization detector |
01/14/2001 | CA2313869A1 Genotyping biallelic markers |
01/14/2001 | CA2313863A1 Use of hemoglobin derivatives for determining plasma and/or blood volume |
01/11/2001 | WO2001002866A1 Diagnostics and therapeutics for arterial wall disruptive disorders |
01/11/2001 | WO2001002865A1 Cyclotron mass spectrometry screening |
01/11/2001 | WO2001002864A1 Methods and kits for diagnosing or monitoring a synovial or osteoarticular pathology comprising the use of a specific marker of the synovial tissue degradation |
01/11/2001 | WO2001002863A1 Diagnostic assay for human matrix gla-protein and its use as a biomarker |
01/11/2001 | WO2001002862A1 Methods to detect protein trafficking disorders |
01/11/2001 | WO2001002861A1 Detection using dendrimers bearing labels and probes |
01/11/2001 | WO2001002860A1 Snail, new tumoral progression marker and target protein of new antitumoral compounds |
01/11/2001 | WO2001002858A1 Immuno-diagnostic test method for veterinary disease |
01/11/2001 | WO2001002857A1 Measurement and use of molecular interactions |
01/11/2001 | WO2001002856A1 Method for determination of peptide-binding agent interaction |
01/11/2001 | WO2001002855A1 Prevention and treatment of amyloid-associated disorders |
01/11/2001 | WO2001002854A1 Analyte detection |
01/11/2001 | WO2001002853A2 DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY |
01/11/2001 | WO2001002852A1 Test method for evaluating soluble polymer growth when recycling inhibitor streams |
01/11/2001 | WO2001002851A1 Method for screening targeting dds preparation |
01/11/2001 | WO2001002848A1 Method for the multi-dimensional analysis of a proteome |
01/11/2001 | WO2001002841A1 Method of measuring consistency of a web, and a measuring device |
01/11/2001 | WO2001002835A1 Method for quantitation of endothelial microparticles |
01/11/2001 | WO2001002834A1 Micro-fabricated solubility measuring system and a method for determining the solubility of a sample |
01/11/2001 | WO2001002833A1 Method and arrangement for measuring characteristics of a non-newtonian fluid |
01/11/2001 | WO2001002831A1 Method and apparatus for measuring retention of a substance |
01/11/2001 | WO2001002828A2 Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |
01/11/2001 | WO2001002609A2 Method of identifying toxic agents using differential gene expression |
01/11/2001 | WO2001002604A1 Use of the krit1 gene in angiogenesis |
01/11/2001 | WO2001002600A2 Detection of analytes using attenuated enzymes |
01/11/2001 | WO2001002599A2 Assay method to identify s-phase cells on cell sections or permeabilised cells and uses thereof |
01/11/2001 | WO2001002598A2 Screening for compounds modulating mitochondrial proton leak |
01/11/2001 | WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
01/11/2001 | WO2001002583A2 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
01/11/2001 | WO2001002569A2 Human immune response molecules |